Europe PMC
Nothing Special   »   [go: up one dir, main page]

Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

Abstract 


No abstract provided.

Free full text 


Logo of bmcidBioMed Central web sitethis articleSearchManuscript submissionRegistrationJournal front page
BMC Infect Dis. 2023; 23: 870.
Published online 2023 Dec 12. https://doi.org/10.1186/s12879-023-08827-3
PMCID: PMC10714593
PMID: 38087225

Correction: Comparison of the clinical characteristics of SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) infected patients from a single hospitalist service

BMC Infectious Diseases 23, 747 (2023)

https://doi.org/10.1186/s12879-023-08714-x

The original publication of this article contained an incorrect caption for Fig. 1. The incorrect and correct information is listed in this correction article. The original article has been updated.

Incorrect

(A) Daily cases during the period of the prospective study of Omicron-infected patients Bracket marks the period when cases were studied. Genomic sequencing of 1 out of 3 patients during this time period revealed 99.2% of cases were the Omicron BA1 variant. (B) Percentage of Delta and Omicron-infected patients who had the reported symptoms associated with their infection. ** p < 0.001 (see Table 1 for statistical analysis). (C) Percentage of Delta and Omicron-infected patients who received each treatment * p = 0.039  0.009. ** p =  < 0.001 (See Table 1 for statistical analysis). (D) Rothman index scores on admission and at the time of death for Omicron and Delta-infected patients who died in the hospital. Bracket marks the statistically significant difference in admission Rothman Index scores, Delta scores being higher (better overall health) than Omicron cases, Mean ± SD 58.2 ± 26.9 n = 8 vs. 34.8 ± 23.0 n = 34. *p = 0.0158.

Correct

(A) Daily cases during the period of the prospective study of Omicron-infected patients Bracket marks the period when cases were studied. Genomic sequencing of 1 out of 3 patients during this time period revealed 99.2% of cases were the Omicron BA1 variant. (B) Percentage of Delta and Omicron-infected patients who had the reported symptoms associated with their infection. ** p < 0.001 (see Table 1 for statistical analysis). (C) Rothman index scores on admission and at the time of death for Omicron and Delta-infected patients who died in the hospital. Bracket marks the statistically significant difference in admission Rothman Index scores, Delta scores being higher (better overall health) than Omicron cases, Mean ± SD 58.2 ± 26.9 n = 8 vs. 34.8 ± 23.0 n = 34. *p = 0.0158(D) Percentage of Delta and Omicron-infected patients who received each treatment * p = 0.039  0.009. ** p =  < 0.001 (See Table 1 for statistical analysis).

Contributor Information

Y. Yang, ude.agu@67807yy.

F. Southwick, ude.lfu.ipe@fhtuos.

Reference

1. Radhakrishnan N, et al. Comparison of the clinical characteristics of SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) infected patients from a single hospitalist service. BMC Infectious Diseases. 2023;23:747. 10.1186/s12879-023-08714-x5. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]

Articles from BMC Infectious Diseases are provided here courtesy of BMC

Similar Articles 


To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.